SCHEMBL14575027

SCHEMBL14575027

CC[C@@H](C)NC(=O)c1ccc(N2CC(CC#N)(n3cc(-c4ncnc5[nH]ccc45)cn3)C2)cc1

nearest known ligand 0.87

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ JAK2 O60674 20/20 0.87
▸ AXL P30530 1/20 0.67
▸ JAK1 P23458 5/20 0.63
▸ JAK3 P52333 5/20 0.63
▸ CIT O14578 1/20 0.63
▸ GAK O14976 1/20 0.63
▸ ROCK2 O75116 1/20 0.63
▸ ULK1 O75385 1/20 0.63
▸ PRKCB P05771 1/20 0.63
▸ RET P07949 1/20 0.63
▸ PRKCA P17252 1/20 0.63
▸ PRKACA P17612 1/20 0.63
▸ MARK3 P27448 1/20 0.63
▸ TYK2 P29597 1/20 0.63
▸ STAT3 P40763 1/20 0.63
▸ CLK1 P49759 1/20 0.63
▸ CSNK1G2 P78368 1/20 0.63
▸ PRKCD Q05655 1/20 0.63
▸ MAP3K1 Q13233 1/20 0.63
▸ ROCK1 Q13464 1/20 0.63

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL14575428 0.95 JAK2 (0.82) JAK2AXLJAK1JAK3CIT
SCHEMBL14331978 0.93 JAK2 (1.00) JAK2AXLJAK1JAK3CIT
SCHEMBL19326987 0.92 JAK2 (0.73) JAK2AXLJAK1JAK3CIT
SCHEMBL14377465 0.91 JAK2 (0.72) JAK2AXLJAK1JAK3CIT
SCHEMBL14331862 0.91 JAK2 (1.00) JAK2AXLJAK1JAK3CIT
SCHEMBL14332136 0.91 JAK2 (1.00) JAK2AXLJAK1JAK3CIT
SCHEMBL14376755 0.91 JAK2 (1.00) JAK2AXLJAK1JAK3CIT
SCHEMBL14332009 0.88 JAK2 (1.00) JAK2AXLJAK1JAK3CIT
Trifluoroacetic Acid SCHEMBL14575175 0.88 JAK2 (0.94) JAK2AXLJAK1JAK3CIT
Trifluoroacetic Acid SCHEMBL14575003 0.88 JAK2 (0.94) JAK2AXLJAK1JAK3CIT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2721028-B1 AZETIDINYL PHENYL, PYRIDYL OR PYRAZINYL CARBOXAMIDE DERIVATIVES AS JAK INHIBITORS INCYTE CORP (US) 2015-11-04 — — EP claimed
US-20150225411-A1 AZETIDINYL PHENYL, PYRIDYL OR PYRAZINYL CARBOXAMIDE DERIVATIVES AS JAK INHIBITORS INCYTE CORPORATION (US) 2015-08-13 — — US claimed
US-9023840-B2 Azetidinyl phenyl, pyridyl or pyrazinyl carboxamide derivatives as JAK inhibitors INCYTE CORPORATION (US) 2015-05-05 — — US claimed
US-20140171409-A1 AZETIDINYL PHENYL, PYRIDYL OR PYRAZINYL CARBOXAMIDE DERIVATIVES AS JAK INHIBITORS INCYTE CORPORATION (US) 2014-06-19 — — US claimed
US-20130018034-A1 AZETIDINYL PHENYL, PYRIDYL OR PYRAZINYL CARBOXAMIDE DERIVATIVES AS JAK INHIBITORS INCYTE CORPORATION (US) 2013-01-17 — — US claimed
US-11214573-B2 Azetidinyl phenyl, pyridyl or pyrazinyl carboxamide derivatives as JAK inhibitors INCYTE HOLDINGS CORPORATION (US) 2022-01-04 — — US disclosed
US-11214573-B2 Azetidinyl phenyl, pyridyl or pyrazinyl carboxamide derivatives as JAK inhibitors INCYTE HOLDINGS CORPORATION (US) 2022-01-04 — — US disclosed
US-20200079783-A1 AZETIDINYL PHENYL, PYRIDYL OR PYRAZINYL CARBOXAMIDE DERIVATIVES AS JAK INHIBITORS INCYTE CORPORATION 2020-03-12 — — US disclosed
US-10513522-B2 Azetidinyl phenyl, pyridyl or pyrazinyl carboxamide derivatives as JAK inhibitors INCYTE CORPORATION (US) 2019-12-24 — — US disclosed
US-10513522-B2 Azetidinyl phenyl, pyridyl or pyrazinyl carboxamide derivatives as JAK inhibitors INCYTE CORPORATION (US) 2019-12-24 — — US disclosed
US-20170253598-A1 AZETIDINYL PHENYL, PYRIDYL OR PYRAZINYL CARBOXAMIDE DERIVATIVES AS JAK INHIBITORS INCYTE CORPORATION 2017-09-07 — — US disclosed
US-20170253598-A1 AZETIDINYL PHENYL, PYRIDYL OR PYRAZINYL CARBOXAMIDE DERIVATIVES AS JAK INHIBITORS INCYTE CORPORATION 2017-09-07 — — US disclosed
US-20140171409-A1 AZETIDINYL PHENYL, PYRIDYL OR PYRAZINYL CARBOXAMIDE DERIVATIVES AS JAK INHIBITORS INCYTE CORPORATION (US) 2014-06-19 — — US disclosed
US-20140171409-A1 AZETIDINYL PHENYL, PYRIDYL OR PYRAZINYL CARBOXAMIDE DERIVATIVES AS JAK INHIBITORS INCYTE CORPORATION (US) 2014-06-19 — — US disclosed
US-20140171409-A1 AZETIDINYL PHENYL, PYRIDYL OR PYRAZINYL CARBOXAMIDE DERIVATIVES AS JAK INHIBITORS INCYTE CORPORATION (US) 2014-06-19 — — US disclosed
US-8691807-B2 Azetidinyl phenyl, pyridyl or pyrazinyl carboxamide derivatives as JAK inhibitors INCYTE CORPORATION (US) 2014-04-08 — — US disclosed
US-8691807-B2 Azetidinyl phenyl, pyridyl or pyrazinyl carboxamide derivatives as JAK inhibitors INCYTE CORPORATION (US) 2014-04-08 — — US disclosed
US-20130018034-A1 AZETIDINYL PHENYL, PYRIDYL OR PYRAZINYL CARBOXAMIDE DERIVATIVES AS JAK INHIBITORS INCYTE CORPORATION (US) 2013-01-17 — — US disclosed
US-20130018034-A1 AZETIDINYL PHENYL, PYRIDYL OR PYRAZINYL CARBOXAMIDE DERIVATIVES AS JAK INHIBITORS INCYTE CORPORATION (US) 2013-01-17 — — US disclosed
US-20130018034-A1 AZETIDINYL PHENYL, PYRIDYL OR PYRAZINYL CARBOXAMIDE DERIVATIVES AS JAK INHIBITORS INCYTE CORPORATION (US) 2013-01-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10513522-B2 Azetidinyl phenyl, pyridyl or pyrazinyl carboxamide derivatives as JAK inhibitors JAK1, JAK3, JAK2 JAK2 3/4885AXL 526/4885JAK1 1/4885
US-20130018034-A1 AZETIDINYL PHENYL, PYRIDYL OR PYRAZINYL CARBOXAMIDE DERIVATIVES AS JAK INHIBITORS JAK1, JAK3, JAK2 JAK2 3/4885AXL 526/4885JAK1 1/4885
US-11214573-B2 Azetidinyl phenyl, pyridyl or pyrazinyl carboxamide derivatives as JAK inhibitors JAK1, JAK3, JAK2 JAK2 3/4885AXL 526/4885JAK1 1/4885
US-20140171409-A1 AZETIDINYL PHENYL, PYRIDYL OR PYRAZINYL CARBOXAMIDE DERIVATIVES AS JAK INHIBITORS JAK1, JAK3, JAK2 JAK2 3/4885AXL 526/4885JAK1 1/4885
US-20170253598-A1 AZETIDINYL PHENYL, PYRIDYL OR PYRAZINYL CARBOXAMIDE DERIVATIVES AS JAK INHIBITORS JAK1, JAK3, JAK2 JAK2 3/4885AXL 526/4885JAK1 1/4885
US-20200079783-A1 AZETIDINYL PHENYL, PYRIDYL OR PYRAZINYL CARBOXAMIDE DERIVATIVES AS JAK INHIBITORS JAK1, JAK3, JAK2 JAK2 3/4885AXL 526/4885JAK1 1/4885
US-20150225411-A1 AZETIDINYL PHENYL, PYRIDYL OR PYRAZINYL CARBOXAMIDE DERIVATIVES AS JAK INHIBITORS JAK1, JAK3, JAK2 JAK2 3/4885AXL 526/4885JAK1 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback